Low-molecularweight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial - Mismetti, P; Mille, D; Laporte, S; Charlet, V; Buchmuller-Cordier, A; Jacquin, JP (Haematologica, 2003)
et al: